Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

par McGurnaghan, S., Blackbourn, L. A. K., Mocevic, E., Haagen Panton, U., McCrimmon, R. J., Sattar, N., Wild, S., Colhoun, H. M.
Publié dans Diabet Med (2018)

Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes

par Fan, X., Ding, Y., Brown, S., Zhou, L., Shaw, M., Vella, M. C., Cheng, H., McNay, E. C., Sherwin, R. S., McCrimmon, R. J.
Publié 2009

Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) proje...

par de Galan, B. E., McCrimmon, R. J., Ibberson, M., Heller, S. R., Choudhary, P., Pouwer, F., Speight, J., Carlton, J., Pieber, T. R., Rosilio, M., Tack, C. J., Müllenborn, M.
Publié dans Diabet Med (2020)

Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour

par Beall, C., Hamilton, D. L., Gallagher, J., Logie, L., Wright, K., Soutar, M. P., Dadak, S., Ashford, F. B., Haythorne, E., Du, Q., Jovanović, A., McCrimmon, R. J., Ashford, M. L. J.
Publié 2012